Incidence of Brain Metastases after Trimodality Therapy in Patients with Esophageal or Gastroesophageal Cancer: Implications for Screening and Surveillance

Publisher： Karger

E-ISSN： 1423-0232|85|4|204-207

ISSN： 0030-2414

Source： Oncology, Vol.85, Iss.4, 2013-09, pp. : 204-207

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patterns of recurrence after trimodality therapy for esophageal cancer

By  

CANCER, Vol. 120, Iss. 14, 2014-07 ,pp. : 2099-2105

John Wiley & Sons Inc

Access to resources Recommend Favorite

Association of treatment factors with surgical outcomes in tri‐modality therapy for esophageal cancer

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 112, Iss. 6, 2015-11 ,pp. : 629-633

John Wiley & Sons Inc

Access to resources Recommend Favorite

Brain Metastases in Very Young Patients with Lung Cancer Are Still Brain Metastases

By  

Oncology Research and Treatment, Vol. 31, Iss. 6, 2008-05 ,pp. : 297-298

Karger

Access to resources Recommend Favorite

Topotecan in the Therapy of Brain Metastases in Lung Cancer

By  

Oncology Research and Treatment, Vol. 21, Iss. 4, 1999-01 ,pp. : 25-27

Karger

Access to resources Recommend Favorite

Outcome of Trimodality-Eligible Esophagogastric Cancer Patients Who Declined Surgery after Preoperative Chemoradiation

By  

Oncology, Vol. 83, Iss. 5, 2012-09 ,pp. : 300-304

Karger

Access to resources Recommend Favorite